Company dossier
Jagsonpal Pharmaceuticals
NSE:JAGSNPHARM · ISIN INE048B01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jagsonpal Pharmaceuticals
Ownership
Shareholding pattern
Exchange XBRLOwnership by reported class
| Holder class | 30 Jun 26 | 09 Jun 26 | 02 Jun 26 | 31 Mar 26 | 31 Dec 25 | 30 Sept 25 |
|---|---|---|---|---|---|---|
| Promoter group | 69.05% | 69.36% | 69.36% | 67.89% | 67.39% | 67.54% |
| Public | 30.95% | 30.64% | 30.64% | 32.11% | 32.61% | 32.46% |
| Employee trust | 0.00% | N/A | 0.00% | 0.00% | 0.00% | 0.00% |
Next ownership layer
Planned enrichmentHolder-level detail
Mutual funds, foreign institutions, insurers, promoter entities, pledges and beneficial-owner changes will be added from detailed shareholding facts. This summary does not infer those classes.